Business Wire

Botify Launches Botify Activation to Accelerate Speed to Market and Content Discoverability for the World’s Most Ambitious Brands

Share

Botify, a leading performance marketing platform for organic search, today announced the launch of Botify Activation to empower organizations to regain control of how search engines and consumers find products and services organically online.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005318/en/

A key suite within the Botify Platform, which already includes Botify Analytics and Botify Intelligence, Botify Activation connects insights about a website’s performance with making brands more discoverable online. By enabling scalable, automated site improvements and content discoverability, Botify Activation provides brands with the ability to expedite how search engines discover and interpret website pages—improving speed to market while also boosting efficiency across teams.

Specifically, Botify Activation is comprised of the following solutions:

  • SpeedWorkers: Serves fully-rendered pages to search engines, ensuring more content can be crawled, indexed, and ultimately found to drive traffic and revenue
  • PageWorkers: Automation capabilities that allow brands to make organic search changes to their website quickly and at scale
  • FastIndex: Easily generate optimized sitemaps to ensure that search engines prioritize the most critical content on your website

"Botify Activation has given us confidence that our strategic pages – ones that drive sales critical to our business – are being found by search engines and by potential buyers. We’ve seen substantial growth in revenue tied to these product pages, which is crucial during the holiday season and throughout the rest of the year,” said Dave Han, VP of Product, Neiman Marcus Group.

Remaining in control of how consumers find content through organic search results, by ensuring search engines can see a brand’s most valuable content, is vital in today’s digital age. In fact, a recent survey conducted by Botify shared that one third of both U.S. and U.K. searchers said they would change their search terms if they were not satisfied with the initial results, as opposed to clicking through multiple results pages.

Botify Activation ensures that consumers find brands’ most relevant and strategic website pages during the initial search, creating touchpoints to maximize online revenue and reduce missed opportunities to connect with potential customers.

“We can rapidly respond to seasonal opportunities on our website quickly with Botify Activation as it enables us to make organic search optimizations at scale, without the need for dev resources. We were able to insert the most relevant Black Friday dynamic keywords across all our product pages in minutes using Botify Activation. Without it, those optimizations would have taken months to be implemented,” said Wayne Burden, Global Head of SEO, Ecco.

Further, in the same survey, more than half of U.S. and U.K. respondents reported that they sometimes follow or convert to a new brand when finding one through search. This demonstrates that meeting consumers at the right moment on their search journey is essential to establishing and building trust—impacting bottom line and future revenue.

“With the current economic uncertainty, companies are forced to do more with less to generate higher profitability. Botify Activation addresses this challenge by empowering search professionals to automatically make website improvements to ensure the utmost visibility,” said Adrien Menard, CEO of Botify. “With optimizations now made within minutes instead of months, for every $1 invested in Botify Activation, they can generate 3x more return than with traditional advertising campaigns.”

Read more about Botify Activation.

About Botify

Botify, a leading performance marketing platform for organic search, strengthens the digital brand experience by creating greater content findability. Using proprietary first-party data, Botify protects and scales organic web traffic by surfacing deeper insights and understanding behind hidden organic search ROI—offering intelligent opportunities to increase relevant search results, profitability and build better brand authority in parallel and at scale.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Natasha Koleas
PAN Communications
949-397-7582
botify@pancomm.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye